Mar 30, 2018· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2018-D-0338-0004
Please find attached NACDS' comments on the Draft Guidance on S&I definitions.
FDANonrulemakingFDA-2018-D-0338
Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act
RIN
—
Last modified
Mar 16, 2023
Comment window
closed 3039d ago
National Association of Chain Drug Stores filings
1
Activity
National Association of Chain Drug Stores filed 1 comment on this docket between Mar 30, 2018 and Mar 30, 2018. 6 other organizations filed here. The comment window closed 3039d ago.
What National Association of Chain Drug Stores filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (6)
See everyone who commented →- National Association of Chain Drug StoresTHIS ORG1 filing · confidence 97%
- American Pharmacists Association (APhA)trade assoc.2 filings · confidence 97%
- Healthcare Distribution Alliancetrade assoc.2 filings · confidence 85%
- Pharmaceutical Distribution Security Alliancetrade assoc.2 filings · confidence 85%
- Healthcare Supply Chain Associationtrade assoc.1 filing · confidence 85%
- McKesson Corporationunverified attribution1 filing · confidence 70%
- National Association of Boards of Pharmacytrade assoc.1 filing · confidence 85%